Veterinary Laboratories Agency, U.K. and Applied Biosystems to Commercialize New Avian Influenza and Newcastle Disease Detection Kit

LONDON--(BUSINESS WIRE)--Applied Biosystems (NYSE: ABI), an Applera Corporation business, and the Veterinary Laboratories Agency (VLA), a UK government agency specializing in animal disease surveillance and veterinary research, today announced a strategic collaboration to manufacture and commercialize the VLA’s molecular avian influenza and Newcastle disease environmental detection kits. These kits are expected to be broadly available in Europe and other parts of the world, such as Asia and Africa. This collaboration is intended to help early detection of these harmful bird diseases, which is a critical step in managing the threat posed by these diseases.

MORE ON THIS TOPIC